CRISM Therapeutics Corporation (AIM:CRTX)
London · Delayed Price · Currency is GBP · Price in GBX 8.50
-0.25 (-2.86%)
Oct 15, 2026, 2:28 PM GMT
CRISM Therapeutics Market Cap
CRISM Therapeutics has a market cap or net worth of 6.73 million as of October 15, 2026. It is the 42,088th most valuable company in the world and the 942nd biggest in the United Kingdom. Its market cap has increased by 53.12% in one year.
Market Cap
6.73M
Enterprise Value
4.46M
Revenue
352.00K
Global Rank
Country Rank
#942 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since March 15, 2006, CRISM Therapeutics's market cap has decreased from 28.23M to 6.73M, a decrease of -76.16%. That is a compound annual growth rate of -6.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 6.73M | 30.10% |
| Dec 31, 2025 | 5.17M | 43.93% |
| Dec 31, 2024 | 3.59M | -74.19% |
| Dec 30, 2022 | 13.93M | -40.80% |
| Dec 31, 2021 | 23.53M | 6.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oxford BioDynamics | 13.44M |
| Palatin Technologies | 12.22M |
| Fusion Antibodies | 12.20M |
| Aptamer Group | 11.23M |
| Thalia Therapeutics | 11.10M |
| Genflow Biosciences | 10.20M |
| Solvonis Therapeutics | 7.83M |
| Cizzle Biotechnology Holdings | 5.95M |